FDA Approves Susvimo for Diabetic Macular Edema
Drugs.com
FEBRUARY 5, 2025
Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic. WEDNESDAY, Feb. 5, 2025 -- The U.S.
Let's personalize your content